Is Manitoba experiencing an Ozempic shortage?

Manitobans who are worried that the Ozempic shortage impacting the United States will reach the province have nothing to worry about, at least for right now, according to experts.
Ozempic is the brand name of a drug called semaglutide, which is used to treat Type 2 diabetes and is part of a class of medications called GLP-1 receptor agonists.
“Essentially it’s a diabetes medication that stimulates the pancreas to produce more insulin when the sugar is high,” explained Dr. Akshay Jain, an endocrinologist and clinical instructor at the University of British Columbia, in an interview on Thursday.
“As an additional effect, it also works on the satiety centre in the brain, so it promotes more satiety and reduces portion sizes.”
Over the last few months, reports have surfaced that Ozempic has been difficult to find in certain parts of the world, including the United States, Australia, Singapore and Southeast Asia. The reason for this shortage has to do with the fact that Ozempic shows results in terms of weight loss.
“The surging worldwide demand of this product due to how effective it is for both diabetes, cardiovascular protection and weight loss have made it very difficult for the manufacturer to keep up with this demand,” said Tim Smith, pharmacy practice advisor with Pharmacists Manitoba, in an interview on Friday.
“There have been intermittent shortages, most in other jurisdictions [other than Canada].”
Jain noted that because Ozempic’s effects are so strong when it comes to weight loss, it has been approved for the management of obesity by the U.S. Food and Drug Administration (FDA) and Health Canada under a different brand name called Wegovy.
He added that because of how common obesity is, Wegovy is in high demand. The demand for the medication has created shortages, which has prompted people to take Ozempic off-label, creating an Ozempic shortage as well.
“It’s the same molecule, but Wegovy is the brand that is approved for the management of obesity and Ozempic is the brand that’s approved for the management of diabetes,” Jain said.
“So people are shunting more of that Ozempic use for the management of obesity, and that has then created a shortage of Ozempic for managing diabetes.”
However, though there have been shortages in other countries, Manitoba and much of Canada have not experienced issues. As for why there are no shortages, there is no definitive answer.
Dr. Isanne Schacter, who works at the Health Sciences Centre and is an assistant professor with the Department of Internal Medicine at the University of Manitoba, suggested that it might have to do with the manufacturer of the Canadian Ozempic supply.
Smith noted the demand for Ozempic is just a lot higher in other parts of the world, particularly in the United States.
“I know the manufacturer is directing a lot of resources to the United States, but why that hasn’t trickled over into more impact here, I’m not sure,” Smith said.
As for whether Manitobans and other Canadians should be concerned about future shortages, it’s not something that can be ruled out entirely.
Smith noted there have been several drug shortages recently, including common drugs such as Amoxicillin and children’s Tylenol.
“Any time a drug that we see is being used by so many people, where there’s threats of a supply chain issues, that’s very concerning to us,” Smith said.
According to Jain, the demand for Ozempic has gone up “quite a bit” amid the off-label usage. He said if this continues and exceeds the supply, then there’s a chance of a potential shortage in the future.
For those who are worried that people with diabetes won’t be able to access the drug due to its usage for weight loss, Smith reminds them that obesity is a chronic disease that is a risk factor for many other health conditions.
He added that it’s important for people with diabetes to have access to Ozempic, but it’s also important to not stigmatize the treatment of obesity and act like it's less important.
“Certainly we want to make sure that people who have diabetes and who are prescribed this medication have access to it, but we shouldn’t be playing one side off of the other,” Smith said.
Smith added that drug shortages are nothing new and that pharmacists, on average, spend upwards of 20 to 25 per cent of their day navigating them.
“So [they are] helping to find alternative brands, alternative products that work similarly or really helping to reinvent the wheel in some cases to make sure that people continue to get the medications that help them to achieve their health goals.”
CTVNews.ca Top Stories
W5 Investigates | How did a healthy teen die at a minor hockey camp?
The parents of young Ontario hockey player Ben Teague have been searching for answers since he died while at a team retreat in 2019. The mystery about what happened and the code of silence in hockey culture is explored in CTV W5's 'What Happened to Ben,' on CTVNews.ca and W5's official YouTube channel.

China's Xi meeting Putin in boost for isolated Russia leader
Chinese leader Xi Jinping is due to meet with Vladimir Putin in a political boost for the isolated Russian president after the International Criminal Court charged him with war crimes in Ukraine.
Trump's call for protests gets muted reaction by supporters
Former U.S. President Donald Trump's calls for protests ahead of his anticipated indictment in New York have generated mostly muted reactions from supporters, with even some of his most ardent loyalists dismissing the idea as a waste of time or a law enforcement trap.
Woman suing Tim Hortons for $500K after hot tea spill left her 'disfigured'
An Ontario woman has launched a lawsuit seeking $500,000 from Tim Hortons after she suffered major burns from an alleged ‘superheated’ tea. The company has denied all allegations and said she was ‘the author of her own misfortune.'
LIVE @ 8 A.M. | Police give update on Old Montreal fire that left 1 dead, 6 missing
Police are giving an update on last week's fire in Old Montreal that killed at least one person and left six missing. Fire services began partially dismantling the building over the weekend, uncovering one body Sunday evening. Several units in the building were unauthorized short-term rentals, or Airbnbs.
Air passenger complaints triple in one year to pass 42,000 as backlog grows
The number of air passenger complaints to Canada's transport regulator is soaring, more than tripling to 42,000 over the past year.
Trails of human bacteria from sneezing and coughing preserved on Mount Everest: study
Even at one of the tallest natural peaks on Earth, humans have left their mark in a trail of bacteria as researchers have found germs from coughing and sneezing that have been potentially preserved for centuries on Mount Everest.
Credit Suisse, UBS shares plunge after takeover announcement
Shares of Credit Suisse plunged 63 per cent in early trading Monday after the announcement that banking giant UBS would buy its troubled rival for almost US$3.25 billion in a deal orchestrated by regulators to stave off further market-shaking turmoil in the global banking system.
Poilievre calling for national standardized test to license doctors, nurses trained outside of Canada
Conservative Leader Pierre Poilievre is calling for a national standardized testing process to be created in order to speed up the licensing process for doctors and nurses who are either immigrants or were trained abroad.